|
Active Pharma Ingredients
|
ACTIVE
PHARMA INGREDIENTS
|
PACKING
(Kgs)
|
|
ACRIFLAVIN
|
5/10
|
|
ACYCLOVIR
|
|
|
AEROSIL
|
10
|
|
ALBENDAZOLE USP
|
25
|
|
ALPRAZOLAM
|
1
|
|
AMITRIPTYLLINE
|
1/5
|
|
AMOXY SODIUM
STERILE
|
10
|
|
AMILODIPINE
|
1/5
|
|
AMOXYCILLIN
TRIHYDRATE
|
10/25
|
|
AMPICILLIN
SODIUM STERILE
|
10
|
|
AMPICILLIN
TRIHYDRATE
|
10/25
|
|
ANALGIN
|
25
|
|
ATENOLOL
|
10
|
|
BROMHEXINE HCL
|
5
|
|
BRONOPOL BP
|
1
|
|
CABOSIL (FUMED
SILICA)
|
5
|
|
CAFFEINE IP
|
10
|
|
CALCIUM D
PANTOTHENATE
|
10/25
|
|
CALCIUM
GLUCONATE IP
|
25
|
|
CALCIUM
GLYCEROPHOSPHATE
|
25
|
|
CARBAMEZEPINE
|
50
|
|
CEPHALEXIN
|
5
|
|
CETRIZINE EP
|
1/5
|
|
CETRIZINE Non
EP
|
1/5
|
|
CHLOROQUIN
PHOSPHATE BP
|
25
|
|
CHLOROXAZONE
|
25
|
|
CHLORPHENIRAMINE
MALEATE
|
5/10
|
|
CIPROFLOXACIN
HCL
|
25
|
|
CISAPRIDE
|
1/5
|
|
CLOTRIMAZOLE
|
50
|
|
CLOXACILLIN
SODIUM STERILE
|
10
|
|
CLOXACILLIN
SODIUM
|
10
|
|
CYPROHEPTADINE
|
1/5
|
|
DICLOFENAC
DIETHYL AMINE BP
|
50
|
|
DICLOFENAC FREE
ACID
|
25
|
|
DICLOFENAC
POTASSIUM IP/BP
|
50
|
|
DICLOFENAC
SODIUM
|
25
|
|
DIETHYL
CARBAMAZINE CITRATE
|
|
|
DIIODOHYDROXYQUINOLINE
|
25
|
|
DILOXANIDE
FUROATE IP
|
25
|
|
DILTIAZAM
|
10
|
|
DIPHENHYDRAMINE
HCL
|
|
|
DOMPERIDONE
|
5/10
|
|
ENROFLOXACIN
|
5
|
|
ERYTHROMYCIN
ESTOLATE
|
25
|
|
ERYTHROMYCIN
STEARATE
|
25
|
|
ETHOPHYLLINE
|
25
|
|
FAMOTIDINE
|
5
|
|
FENBENDAZOLE
|
25
|
|
FERROUS
FUMARATE
|
25
|
|
FERROUS
GLUCONATE
|
25
|
|
FLUCONAZOLE EP
|
5
|
|
FLUCONAZOLE
Non-EP
|
5
|
|
FLUOXETINE HCL
|
5/10
|
|
FOLIC ACID
|
10/25
|
|
FUNGAL DIASTASE
|
10/25
|
|
FRUSEMIDE IP
|
25
|
|
FUROZOLIDONE IP
|
25
|
|
GENTAMYCIN
SULPHATE
|
5
|
|
GLUCOSAMINE
SODIUM
|
25
|
|
GRISEOFULVIN
|
|
|
GUAFENISIN USP
(GG Ether)
|
25
|
|
HALAZONE USP
|
|
|
HALOPERIDONE
|
1/5
|
|
IBUPROFEN
|
25
|
|
IMIPRAMINE
HYDROCHLORIDE
|
|
|
IODOCHLOROHYDROXYQUINOLINE
|
25
|
|
IRON (III)
HYDROXIDE POLYMALTOSE
|
25
|
|
ISONIAZIDE IP
|
25
|
|
LACTIC ACID
BACILLUS
|
1/5
|
|
LANSOPRAZOLE
PELLETS 8.5%
|
1
|
|
LIGNOCAINE BASE
|
|
|
LIGNOCAINE
HYDROCHLORIDE
|
|
|
LOMEFLOXACIN
|
1/10
|
|
LOPERIMIDE
|
1/5
|
|
LORATIDINE
|
1/5
|
|
L-LYSINE FEED
GRADE
|
25
|
|
L-LYSINE PHARMA
GRADE
|
25
|
|
MANNITOL
|
25
|
|
MEBENDAZOLE
|
25
|
|
METACLOPRAMIDE
HCL BP
|
10
|
|
METFORMIN HCL
|
50
|
|
METHOCARBAMOL
|
25
|
|
METRONIDAZOLE
IP
|
25
|
|
METRONIDAZOLE
BENZOATE
|
25
|
|
MICONAZOLE
NITRATE
|
10/25
|
|
MOSAPRIDE
|
1
|
|
NALIDIXIC ACID
|
25
|
|
NEFIDIPINE
|
25
|
|
NEOMYCIN
SULPHATE
|
|
|
NIACIN
|
25
|
|
NIACINAMIDE
|
25
|
|
NIMSULIDE
|
25
|
|
NIPAGIN PLAIN
(Methyl Paraben)
|
10
|
|
NIPAGIN SODIUM
|
10
|
|
NORFLOXACIN USP
|
10/25
|
|
OMEPRAZOLE DRUG
|
|
|
OMEPRAZOLE
MAGNESIUM
|
|
|
OMEPRAZOLE
PELLETS 7.5%
|
|
|
OMEPRAZOLE
PELLETS 8.5%
|
|
|
OXCARBAMAZEPINE
|
50
|
|
PAPAIN 1:350
|
|
|
PARACETAMOL
|
50
|
|
PEFLOXACIN
|
10
|
|
PENTAPRAZOLE
|
5
|
|
PHENYLEPHERINE
|
1
|
|
PHENYTOIN
SODIUM
|
25
|
|
PHTHALYSULPHATHIAZOLE
|
|
|
PIOGLITAZONE
HCL
|
20
|
|
PIPERAZINE
ADIPATE
|
|
|
PIPERAZINE
CITRATE
|
|
|
PIPERAZINE
PHOSPHATE
|
|
|
POTASSIUM
CHLORIDE BP
|
50
|
|
POTASSIUM
IODIDE
|
25
|
|
PROPRANOLOL HCL
|
25
|
|
PROPYL PARABEN
|
10/25
|
|
PROPYL PARABEN
SODIUM
|
10/25
|
|
PROPYPHENAZONE
POWDER IP
|
25
|
|
PYREMETHAMINE
|
|
|
PYROXICAM
|
|
|
RABEPRAZOLE
|
|
|
RALOXIFINE HCL
|
|
|
RANITIDINE USP
|
25
|
|
ROFECOXIB
|
5/10
|
|
ROXYTHROMYCIN
|
1/5
|
|
SACCHARIN
SODIUM
|
25
|
|
SACCHAROMYCES
BOULARDII
|
1
|
|
SALBUTAMOL
SULPHATE
|
5
|
|
SERTRALINE HCL
|
10
|
|
SIMETHICONE IP
|
5
|
|
SODIUM
ASCORBATE
|
50
|
|
SODIUM
GLYCEROPHOSPHATE
|
|
|
SODIUM IODIDE
|
|
|
SPARFLOXACIN
|
5
|
|
SULPHADIAZINE
|
|
|
SULPHADOXINE
|
|
|
TERBUTALINE
SULPHATE BP
|
1/5
|
|
THEOPHYLLINE
ANHYDROUS
|
25
|
|
TINIDAZOLE
|
|
|
TIZANIDINE
HYDROCHLORIDE
|
1
|
|
TRIFLUOPERAZINE
HYDROCHLORIDE
|
1/5
|
|
TRIMETHOPRIM IP
|
5
|
|
VENLAFAXINE HCL
|
10
|
|
VITAMIN B1 HCL
|
5
|
|
VITAMIN B1 Mono
|
5
|
|
VITAMIN B2-5
PHOSPHATE
|
|
|
VITAMIN B6
HYDROCHLORIDE
|
5/10
|
|
VITAMIN C
COATED
|
50
|
|
VITAMIN C PLAIN
|
50
|
Note
APIs / Substances covered by patents
are not offered to the countries where valid Patent Law is in force.
However, the final responsibility lies with the customer.
|